Original document(102 pages)  中文版
    A platelet aggregation inhibitor comprising a quinolone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a novel quinolone derivative or a pharmaceutically acceptable salt thereof useful as a platelet aggregation inhibitor.
Application Number
申请号		 200480021187 Application Date
申请日		 2004.07.22
Title 名称 Quinolone derivative or its salt
Publication Number
公开号		 1826321 Publication Date
公开日		 2006.08.30
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D215/56,A61K31/4709,C07D405/12,C07D401/06,C07D401/14,C07D417/12,C07D413/12,C07D409/12,A61K31/4725,C07D401/04,C07D405/06,C07D405/04,C07F9/60,A61P7/02,A61P9/10,A61P41/00
Applicant(s) Name
申请人		 Yamanouchi Pharma Co., Ltd.
Address 地址
Inventor(s) Name 发明人 Watanuki Susumu, Koga Yuji, Moritomo Hiroyuki, Tsukamoto Kazunari, Kaga Daisuke, Okuda Takao, Hirayama Fukushi, Moritani Yumiko
Attorney & Agent 代理人 chen wenjing

  
Medicine comprising dicyanopyridine derivative
Arylethenesulfonamide derivatives and drug composition containing the same
2-acylaminothiazole derivative or salt thereof
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
4,5-dihydro-imidazole as P2X7 ion channel blockers
Method for the production of purified 1,3-substituted imidazolium salts
2-substituted pyrimidines
Substituted pyridin-2-ylamine analogues
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.